Congress Asset Management Co. Has $160.57 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Congress Asset Management Co. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 307,630 shares of the medical equipment provider’s stock after buying an additional 364 shares during the quarter. Intuitive Surgical makes up approximately 1.1% of Congress Asset Management Co.’s investment portfolio, making the stock its 14th largest position. Congress Asset Management Co.’s holdings in Intuitive Surgical were worth $160,571,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical in the third quarter valued at approximately $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on ISRG shares. Jefferies Financial Group upped their target price on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Leerink Partners boosted their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Truist Financial boosted their price target on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Royal Bank of Canada boosted their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, CICC Research began coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target for the company. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 6,348 shares of company stock worth $3,587,582. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $595.55 on Friday. The company has a fifty day moving average of $559.48 and a 200-day moving average of $519.06. The company has a market capitalization of $212.12 billion, a PE ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.